William S. Hancock

Faculty Fellow, Bradstreet Chair in Bioanalytical Chemistry

Co-chair, trans-NIH Alliance of Glycobiologistsfor Detection of Cancer and Cancer Risk

editor-in-chief, Journal of Proteome Research (ACS)

The Barnett Institute,
341 Mugar Hall
Northeastern University
360 Huntington Avenue
Boston, MA 02115
e-mail: wi.hancock@neu.edu
voice: 617-373-4881
fax: 617-373-2855

Hancock Barnett Institute Page

Hancock Research Group Page

Hancock Chem. Dept. Page

Education

1970 Ph.D., Adelaide University,
South Australia

1966 B.Sc., Adelaide University,
South Australia

Research Interests

We have formed a tumor glycome laboratory team with multi-disciplinary expertise in glycomics, proteomics, informatics, and cancer markers to apply an integrated glycoproteomics approach to discover glycan biomarkers for early detection of cancer. One major goal is focused on the analysis and identification of glycoproteins in plasma and tissue to detect differences between breast cancer subjects and controls. We are developing analytical approaches to identify and characterize the glycan changes associated with these glycoproteins. At present we have combined the multi-lectin platform (M-LAC) with 1D-SDS PAGE, lectin blotting and proteomic analysis as well as deeper fractionation on the new Protein Forest IEF chip. For glycoproteins of interest, the number of glycosylation sites, the attachment point of the glycan to the polypeptide backbone and the accurate mass and fragmentation pattern of individual glycopeptides in the LT-FTMS and LTMS with both CID and ETD will be determined. Additionally glycans will be cleaved and their structure determined after permethylation by MALDI-TOF analysis of the resulting glycan HPLC profiles. Candidate glycoprotein markers resulting from these studies will be prioritized based on elevated levels in both breast tumor tissue and plasma and occurrence of altered glycosylation. In addition, we are studying the glycan structures of the secreted form of EGFR from A431 cell lines as a model system for understanding potential glycosylation differences between secreted and plasma membrane forms of cancer associated signaling molecules. We plan to achieve the translational aspect of this study by the application of a high throughput and sensitive glycan assay platform which will be used to pre-validate markers in a large sample set and thus facilitate subsequent clinical studies. Currently we are investigating the application of the antibody-lectin array approach in collaboration with the Haab laboratory and a targeted MRM approach.       


Recent Invited Lectures:
(1) 6th Early Detection Research Network (EDRN) Scientific Workshop and NCI Alliance of Glycobiologists Meeting, September 3rd, Bethesda, MD, USA,"Glycan Markers for the Early Detection of Cancer".
     
(2)   State of the Art Protein Analysis and Regulatory Science, August 31st to September 3rd, 2009, Boston, MA, "Modifications of Biopharmaceuticals".
     
(3) HPLC 2009, June 28th to July 2nd, 2009, Dresden, Germany, "The Role of HPLC in the Discovery of Glycoprotein (Glycan) Markers for the Early Detection of Cancer".
     
(4)   Clinical and Translational Research on Cancer: Glycomics Applications, March 24th to 27th, Toba, Japan, "Glycoprotein Markers for the Early Detecion of Cancer".
     
     
Recent Awards (Partial Listing):
(1)   President, US HUPO, 2008
     
(2)   Randolph T. Major Memorial Lecturer (R.T.Major Lecture Series, Dept. of Chem., Univ. of Connecticut, 2004)
     
(3) ACS Award in Separation Science (ACS
National Meeting, 2003)

Publications:
206 scientific publications, plus 7 books
and 21 patents.
 
Complete List of Publications
Current Pubmed search "W.S. Hancock"

Selected Recent Publications:
(1) Zeng, Z., Hincapie, M., Haab, B.B., Hanash, S., Pitteri, S.J., Kluck, S., Hogan, J.M., Kennedy, J. and Hancock, W.S.,"The Development of an Integrated Platform to Identify Breast Cancer Glycoproteome Changes in Human Serum", J Chromatogr A., (2009) Sep 16. [Epub ahead of print]. (pubmed)
     
(2) Lu, Q., Zheng, X., McIntosh, T., Davis, H., Nemeth, J.F., Pendley, C., Wu, S.-L and Hancock W.S., "Development of Different Analysis Platforms with LC-MS for Pharmacokinetic Studies of Protein Drugs", Anal. Chem. (2009) Nov 1;81(21):8715-23. (pubmed)
     
(3) Akella, L.M., Rejtar, T., Orazine, C., Hincapie, M. and Hancock, W.S., "CLUE-TIPS, Clustering Methods for Pattern Analysis of LC-MS Data", J Proteome Res. (2009) Oct;8(10):4732-42. (pubmed)
     
(4) Taylor, A.D., Hancock, W.S., Hincapie, M., Taniguchi, N. and Hanash, S.M., "Towards an Integrated Proteomic and Glycomic Approach to Finding Cancer Biomarkers", Genome Med., Jun 4, 1(6):57, (2009). (pubmed)
     
(5)   Bell, A.W., et al,"A HUPO Test Sample Study Reveals Common Problems in Mass Spectrometry-Based Proteomics", Nat Methods, (2009) 6(6), 423-30. (pubmed)
     
(6)   Jiang, H., Wu, S-L., Karger,B.L. and Hancock, W.S., "Mass Spectrometric Analysis of Innovator, Counterfeit, and Follow-On Recombinant Human Growth Hormone", Biotechnol. Prog., Jan.-Feb., 25(1), 207-18 (2009). (pubmed)
     
(7)   Zheng, X., Wu, S-L., Hincapie, M. and Hancock, W.S.,"Study of the Human Plasma Proteome of Rheumatoid Arthritis", J. Chromatogr. A, 1216(16), 3538-45 (2009). (pubmed) .
 
(8)   Wu, S-L., Jiang, H., Lu, Q., Dai, S., Hancock, W.S. and Karger, B.L., "Mass Spectrometric Determination of Disulfide Linkages in Recombinant Therapeutic Proteins Using Online LC-MS with Electron-Transfer Dissociation", Anal. Chem., 81, 1, 112-122 (2009).(link)
 
(9)   Ochoa, C.D., Baker, H., Hasak, S., Matyal, R., Salam, A., Hales, C.A., Hancock, W.S. and Quinn, D.A., "Cyclic Stretch Affects Pulmonary Endothelial Cell Control of Pulmonary Smooth Muscle Cell Growth", Am. J. Respir. Cell Mol. Biol. 1, 105-112 (2008). (pubmed)
 
(10)   Pandey, A., et. al., (Hancock W.S.) "Human Proteinpedia enables sharing of human protein data", Nat Biotechnol. , Feb;26(2):164-7 (2008).(pubmed)
 
(11)   Kullolli, M., Hancock, W.S., Hincapie, M.,  "Preparation of a high-performance multi-lectin affinity chromatography (HP-M-LAC) adsorbent for the analysis of human plasma glycoproteins", J, Sep Sci. (14):2733-9 (2008).(pubmed)
     
(12) Lu, C., Murugesan, N.. Macdonald, J. A, Wu, S. L., Pachter, J.  and  Hancock, W. S., "Analysis of Mouse Brain Microvascular Endothelium Using Immuno-Laser Capture Microdissection Coupled to a Hybrid LTQ-FT MS Proteomics Platform”, Electrophoresis, 2689-95 (2008).(pubmed)
     
(13)   Ralin, D.W., Dultz, S.C., Silver, J.E., Kullolli, M., Hancock, W.S. and Hincapie, M., "Kinetic Analysis of Glycoprotein-lectin Interactions by Label- Free Internal Reflection”, Clin. Proteomics, 4,37-46. (2008).(link)
     
(14)   Plavina, T., Hincapie, M., Wakshull, E., Subramanyam M., and Hancock, W.S., “Increased Levels of Cytoskeletal and Ca2+-Binding Proteins and their Peptides in Plasma of Psoriasis Patients”, Clin. Chem., 54,1805-1814 (2008).(pubmed)
     
(15)   Dayarathna, M.K., Hancock, W.S. and Hincapie, M., "A Two-Step Fractionation Approach for Plasma Proteomics Using Immunodepletion of Abundant Proteins and Multi-lectin Affinity Chromatography (M-LAC): Application to the Analysis of Obesity, Diabetes and Hypertension,", J. Sep. Science, 1156-1166 (2008).(pubmed)
     
(16)   Orazine, C. I., Hincapie, M., Hancock, W.S., Hattersley, M., and Hanke, J., "A Proteomic Analysis of the Plasma Glycoproteins of a MCF-7 Mouse Xenograft : A Model System for the Detection of Tumor Markers", J. Prot. Res., 7, 1542-54 (2008). (pubmed)

Last Updated 3/30/10

| Home | News | Members | Research Programs | Research Groups | Instrumentation |
| Publications | Jobs | Events | | Collaborations | Suggestions and Comments |